Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

October 31, 2012

Study Completion Date

December 31, 2012

Conditions
Sexual Dysfunction, Physiological
Interventions
DRUG

Testosterone Cream

1% micronized in velvachol - 0.5 gm of cream vaginally each night for two weeks, then 3 times a week for total of 12 weeks of treatment

DRUG

Estring

2mg ring inserted vaginally once every 12 weeks

Trial Locations (1)

94115

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT00698035 - Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients | Biotech Hunter | Biotech Hunter